Source: Google NewsPublished on 2021-06-28
Related Articles:
- Use of Cannabidiol (CBD) for PD symptoms February 9, 2021 Understanding CBD People with PD are eager to find alternative methods to help their symptoms, leading many of these patients to look into whether other therapies, such as medical marijuana, also known as medical cannabis, can be useful. Previously, I wrote a blog on medical marijuana and PD which you may find interesting. More recently, I have received many inquiries specifically…
- Cannabis and Parkinson’s: What to Know About Medical Marijuana, CBD, and more March 25, 2021 Although there is insufficient evidence that recommends using cannabis to treat Parkinson’s motor symptoms, a growing number of people with Parkinson’s are experimenting with it to help ease their symptoms. Others who have not experimented with cannabis products, such as medical marijuana and CBD, are expressing more interest in the subject. Yet, many people do not fully understand the chemical and biological makeup of cannabis plants, the different types of cannabis products, and what the research says about the effects on Parkinson’s symptoms. A February 2021 study, published in the Journal of Parkinson’s Disease, reported that while…
- Could CBD Help to Ease Parkinson’s Symptoms? February 19, 2020 As a Colorado resident, I often wonder about the healing power of plants. We live in a time when the pharmaceutical industry is booming. Pills exist to tame nearly any symptom, but they often can have unwanted side effects. The side effects of plants, however, may be less harsh, or even nonexistent. Cannabidiol (CBD) is a great example of this…
- Guest Post: 5 Studies that Show Hope for CBD Treating Parkinson’s February 9, 2020 by John Alois These days most people have heard something or other about the potential of CBD to treat symptoms associated with various conditions. With the explosion of peer-reviewed research on the topic over the last two decades, we now know a ton about the value of this plant-based medication that comes in many different forms. While many have heard…
- Guest Post: 5 Studies that Show Hope for CBD Treating Parkinson’s February 9, 2020 by John Alois These days most people have heard something or other about the potential of CBD to treat symptoms associated with various conditions. With the explosion of peer-reviewed research on the topic over the last two decades, we now know a ton about the value of this plant-based medication that comes in many different forms. While many have heard…
- Guest Post: 5 Studies that Show Hope for CBD Treating Parkinson’s February 9, 2020 by John Alois These days most people have heard something or other about the potential of CBD to treat symptoms associated with various conditions. With the explosion of peer-reviewed research on the topic over the last two decades, we now know a ton about the value of this plant-based medication that comes in many different forms. While many have heard…
- Guest Post: 5 Studies that Show Hope for CBD Treating Parkinson’s February 9, 2020 by John Alois These days most people have heard something or other about the potential of CBD to treat symptoms associated with various conditions. With the explosion of peer-reviewed research on the topic over the last two decades, we now know a ton about the value of this plant-based medication that comes in many different forms. While many have heard…
- Guest Post: 5 Studies that Show Hope for CBD Treating Parkinson’s February 9, 2020 by John Alois These days most people have heard something or other about the potential of CBD to treat symptoms associated with various conditions. With the explosion of peer-reviewed research on the topic over the last two decades, we now know a ton about the value of this plant-based medication that comes in many different forms. While many have heard…
- Cannabidiol Found to Reduce Anxiety-induced Tremors in Parkinson’s Patients, Study Shows January 21, 2020 A single dose of cannabidiol (CBD) can decrease anxiety and tremor strength in people with Parkinson’s disease during situations known to induce anxiety, such as a public speaking exercise, a study found. The results of the study, “Effects of acute cannabidiol administration on anxiety and tremors induced by a Simulated Public Speaking Test in patients with Parkinson’s disease,” were published…
- Selling cannabidiol products in Canada: A framing analysis of advertising claims by online retailers July 2, 2021 BMC Public Health. 2021 Jul 1;21(1):1285. doi: 10.1186/s12889-021-11282-x.ABSTRACTBACKGROUND: In Canada, the legalization of cannabis has enabled cannabidiol (CBD) to become a popular commercial product, increasingly used for medical or therapeutic purposes. There are currently over one thousand CBD products available globally, ranging from oil extracts to CBD-infused beverages. Despite increased usage and availability, the evidence supporting the medical efficacy of…
- Selling cannabidiol products in Canada: A framing analysis of advertising claims by online retailers July 2, 2021 BMC Public Health. 2021 Jul 1;21(1):1285. doi: 10.1186/s12889-021-11282-x.ABSTRACTBACKGROUND: In Canada, the legalization of cannabis has enabled cannabidiol (CBD) to become a popular commercial product, increasingly used for medical or therapeutic purposes. There are currently over one thousand CBD products available globally, ranging from oil extracts to CBD-infused beverages. Despite increased usage and availability, the evidence supporting the medical efficacy of…
- Selling cannabidiol products in Canada: A framing analysis of advertising claims by online retailers July 2, 2021 BMC Public Health. 2021 Jul 1;21(1):1285. doi: 10.1186/s12889-021-11282-x.ABSTRACTBACKGROUND: In Canada, the legalization of cannabis has enabled cannabidiol (CBD) to become a popular commercial product, increasingly used for medical or therapeutic purposes. There are currently over one thousand CBD products available globally, ranging from oil extracts to CBD-infused beverages. Despite increased usage and availability, the evidence supporting the medical efficacy of…
- Selling cannabidiol products in Canada: A framing analysis of advertising claims by online retailers July 2, 2021 BMC Public Health. 2021 Jul 1;21(1):1285. doi: 10.1186/s12889-021-11282-x.ABSTRACTBACKGROUND: In Canada, the legalization of cannabis has enabled cannabidiol (CBD) to become a popular commercial product, increasingly used for medical or therapeutic purposes. There are currently over one thousand CBD products available globally, ranging from oil extracts to CBD-infused beverages. Despite increased usage and availability, the evidence supporting the medical efficacy of…
- Selling cannabidiol products in Canada: A framing analysis of advertising claims by online retailers July 2, 2021 BMC Public Health. 2021 Jul 1;21(1):1285. doi: 10.1186/s12889-021-11282-x.ABSTRACTBACKGROUND: In Canada, the legalization of cannabis has enabled cannabidiol (CBD) to become a popular commercial product, increasingly used for medical or therapeutic purposes. There are currently over one thousand CBD products available globally, ranging from oil extracts to CBD-infused beverages. Despite increased usage and availability, the evidence supporting the medical efficacy of…
- The “What would I do” post? Part 2 January 22, 2022 # # # # I am very regularly asked “what would you do if you were diagnosed with Parkinson’s tomorrow?” As a research scientist I don’t really feel comfortable answering it, but I can see how it is a fair question. I have previously attempted to address it (Click here to read that post), and I point folks who do…
- Interacting binding insights and conformational consequences of the differential activity of cannabidiol with two endocannabinoid-activated G-protein-coupled receptors August 26, 2022 Front Pharmacol. 2022 Aug 9;13:945935. doi: 10.3389/fphar.2022.945935. eCollection 2022.ABSTRACTCannabidiol (CBD), the major non-psychoactive phytocannabinoid present in the plant Cannabis sativa, has displayed beneficial pharmacological effects in the treatment of several neurological disorders including, epilepsy, Parkinson's disease, and Alzheimer's disease. In particular, CBD is able to modulate different receptors in the endocannabinoid system, some of which belong to the family of…
- Interacting binding insights and conformational consequences of the differential activity of cannabidiol with two endocannabinoid-activated G-protein-coupled receptors August 26, 2022 Front Pharmacol. 2022 Aug 9;13:945935. doi: 10.3389/fphar.2022.945935. eCollection 2022.ABSTRACTCannabidiol (CBD), the major non-psychoactive phytocannabinoid present in the plant Cannabis sativa, has displayed beneficial pharmacological effects in the treatment of several neurological disorders including, epilepsy, Parkinson's disease, and Alzheimer's disease. In particular, CBD is able to modulate different receptors in the endocannabinoid system, some of which belong to the family of…
- Interacting binding insights and conformational consequences of the differential activity of cannabidiol with two endocannabinoid-activated G-protein-coupled receptors August 26, 2022 Front Pharmacol. 2022 Aug 9;13:945935. doi: 10.3389/fphar.2022.945935. eCollection 2022.ABSTRACTCannabidiol (CBD), the major non-psychoactive phytocannabinoid present in the plant Cannabis sativa, has displayed beneficial pharmacological effects in the treatment of several neurological disorders including, epilepsy, Parkinson's disease, and Alzheimer's disease. In particular, CBD is able to modulate different receptors in the endocannabinoid system, some of which belong to the family of…
- Interacting binding insights and conformational consequences of the differential activity of cannabidiol with two endocannabinoid-activated G-protein-coupled receptors August 26, 2022 Front Pharmacol. 2022 Aug 9;13:945935. doi: 10.3389/fphar.2022.945935. eCollection 2022.ABSTRACTCannabidiol (CBD), the major non-psychoactive phytocannabinoid present in the plant Cannabis sativa, has displayed beneficial pharmacological effects in the treatment of several neurological disorders including, epilepsy, Parkinson's disease, and Alzheimer's disease. In particular, CBD is able to modulate different receptors in the endocannabinoid system, some of which belong to the family of…
- Interacting binding insights and conformational consequences of the differential activity of cannabidiol with two endocannabinoid-activated G-protein-coupled receptors August 26, 2022 Front Pharmacol. 2022 Aug 9;13:945935. doi: 10.3389/fphar.2022.945935. eCollection 2022.ABSTRACTCannabidiol (CBD), the major non-psychoactive phytocannabinoid present in the plant Cannabis sativa, has displayed beneficial pharmacological effects in the treatment of several neurological disorders including, epilepsy, Parkinson's disease, and Alzheimer's disease. In particular, CBD is able to modulate different receptors in the endocannabinoid system, some of which belong to the family of…
- Interacting binding insights and conformational consequences of the differential activity of cannabidiol with two endocannabinoid-activated G-protein-coupled receptors August 26, 2022 Front Pharmacol. 2022 Aug 9;13:945935. doi: 10.3389/fphar.2022.945935. eCollection 2022.ABSTRACTCannabidiol (CBD), the major non-psychoactive phytocannabinoid present in the plant Cannabis sativa, has displayed beneficial pharmacological effects in the treatment of several neurological disorders including, epilepsy, Parkinson's disease, and Alzheimer's disease. In particular, CBD is able to modulate different receptors in the endocannabinoid system, some of which belong to the family of…
- Cannabidiol attenuates fear memory expression in female rats via hippocampal 5-HT1A but not CB1 or CB2 receptors November 5, 2022 Neuropharmacology. 2022 Nov 2:109316. doi: 10.1016/j.neuropharm.2022.109316. Online ahead of print.ABSTRACTGrowing evidence from male rodent and human studies suggests that cannabidiol (CBD) modulates the expression of aversive memories and anxiety-related responses. The limited data on whether and how CBD influences these aspects in females could have therapeutic implications given the increased susceptibility of women to anxiety- and stress-related disorders relative to…